Nutritional background changes the hypolipidemic effects of fenofibrate in Nile tilapia (Oreochromis niloticus)

Sci Rep. 2017 Jan 31:7:41706. doi: 10.1038/srep41706.

Abstract

Peroxisome proliferation activated receptor α (PPARα) is an important transcriptional regulator of lipid metabolism and is activated by high-fat diet (HFD) and fibrates in mammals. However, whether nutritional background affects PPARα activation and the hypolipidemic effects of PPARα ligands have not been investigated in fish. In the present two-phase study of Nile tilapia (Oreochromis niloticus), fish were first fed a HFD (13% fat) or low-fat diet (LFD; 1% fat) diet for 10 weeks, and then fish from the first phase were fed the HFD or LFD supplemented with 200 mg/kg body weight fenofibrate for 4 weeks. The results indicated that the HFD did not activate PPARα or other lipid catabolism-related genes. Hepatic fatty acid β-oxidation increased significantly in the HFD and LFD groups after the fenofibrate treatment, when exogenous substrates were sufficiently provided. Only in the HFD group, fenofibrate significantly increased hepatic PPARα mRNA and protein expression, and decreased liver and plasma triglyceride concentrations. This is the first study to show that body fat deposition and dietary lipid content affects PPARα activation and the hypolipidemic effects of fenofibrate in fish, and this could be due to differences in substrate availability for lipid catabolism in fish fed with different diets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cichlids / physiology*
  • Diet, High-Fat
  • Fatty Acids / metabolism
  • Fenofibrate / pharmacology*
  • Gene Expression Regulation / drug effects
  • Hypolipidemic Agents / pharmacology*
  • Lipid Metabolism / drug effects
  • Nutritional Physiological Phenomena*
  • Organ Specificity / genetics
  • Oxidation-Reduction
  • PPAR alpha / genetics
  • PPAR alpha / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism

Substances

  • Fatty Acids
  • Hypolipidemic Agents
  • PPAR alpha
  • RNA, Messenger
  • Fenofibrate